{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04993",
      "entity_text" : "imaging alphavbeta3",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0895" ],
      "Organ" : [ "uberon:UBERON:0000468" ]
    }
  },
  "verbose_text" : "Recently, the SPECT tracer [99m Tc] NC100692 was introduced by GE healthcare for imaging alphavbeta3 expression in humans and was first evaluated in breast cancer by Bach-Gansmo et al. 19 of 22 tumors could be detected with this agent, which was safe and well tolerated by the patients XREF_BIBR.",
  "reading_complete" : "2020-08-02T13:25:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:18:54Z",
  "trigger" : "expression",
  "evidence" : [ "imaging alphavbeta3 expression" ],
  "pmc_id" : "3086612",
  "score" : 0
}